Table 1.

Target ligand expression on EC-RF24 cells and HUVECs by flow cytometry


Antibody (target)

% Positive EC-RF24 cells (MFI)

% Positive HUVECs (MFI)
P3 (negative control)   1 (6)   1 (8)  
7E3 (αvβ3 + αIIbβ3)   90 (117)   53 (101)  
LM609 (αvβ3)   89 (112)   48 (81)  
10E5 (αIIbβ3)   2 (26)   2 (12)  
1951Z-20 (β1 integrin)   99 (119)   63 (96)  
A3D8 (CD44)   81 (233)   67 (316)  
MP30-1 (CD4-7)   99 (115)   39 (51)  
Rabbit antilaminin   52 (56)   7 (9)  
BS46 (LW)
 
1 (6)
 
1 (21)
 

Antibody (target)

% Positive EC-RF24 cells (MFI)

% Positive HUVECs (MFI)
P3 (negative control)   1 (6)   1 (8)  
7E3 (αvβ3 + αIIbβ3)   90 (117)   53 (101)  
LM609 (αvβ3)   89 (112)   48 (81)  
10E5 (αIIbβ3)   2 (26)   2 (12)  
1951Z-20 (β1 integrin)   99 (119)   63 (96)  
A3D8 (CD44)   81 (233)   67 (316)  
MP30-1 (CD4-7)   99 (115)   39 (51)  
Rabbit antilaminin   52 (56)   7 (9)  
BS46 (LW)
 
1 (6)
 
1 (21)
 

Indirect immunofluorescence assays were performed on EC-RF24 cells and HUVECs. 7E3 (anti-αVβ3 and -αIIβ3), LM609 (anti-αvβ3), 10E5 (anti-αIIbβ3), 1951Z-20 (anti-β1), A3D8 (anti-CD44), MP30-1 (anti-CD47), and anti-LW mouse antihuman mAbs were used at 5 μg/mL. P3 (as a negative control) was used as ascitic fluid diluted 1:500. Rabbit antihuman laminin mAb was diluted 1:500. Percentage and mean fluorescence intensity (MFI) of positive cells are shown.

Close Modal

or Create an Account

Close Modal
Close Modal